HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marta Kubera Selected Research

Catenins

1/2022Aberrations in the Cross-Talks Among Redox, Nuclear Factor-κB, and Wnt/β-Catenin Pathway Signaling Underpin Myalgic Encephalomyelitis and Chronic Fatigue Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marta Kubera Research Topics

Disease

15Inflammation (Inflammations)
01/2018 - 12/2007
13Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
01/2022 - 08/2007
12Fatigue
01/2022 - 08/2007
7Neoplasms (Cancer)
01/2023 - 11/2009
6Schizophrenia (Dementia Praecox)
02/2020 - 11/2003
5Depressive Disorder (Melancholia)
02/2020 - 11/2009
5Contact Dermatitis (Eczema, Contact)
01/2017 - 01/2012
5Neuroblastoma
11/2009 - 04/2004
5Treatment-Resistant Depressive Disorder
11/2009 - 02/2004
4Neoplasm Metastasis (Metastasis)
01/2023 - 11/2009
4Infections
01/2022 - 08/2007
4Mood Disorders (Mood Disorder)
01/2022 - 01/2013
4Melanoma (Melanoma, Malignant)
01/2013 - 11/2009
3Wounds and Injuries (Trauma)
01/2022 - 12/2010
3Insulin Resistance
01/2022 - 01/2013
3Psychotic Disorders (Schizoaffective Disorder)
02/2020 - 11/2002
3Anhedonia
07/2017 - 07/2013
3Medically Unexplained Symptoms
09/2013 - 02/2012
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2011 - 01/2009
3Seizures (Absence Seizure)
09/2007 - 11/2003
2Bipolar Disorder (Manic Depressive Psychosis)
02/2020 - 02/2020
2Obesity
03/2018 - 01/2011
2Brain Diseases (Brain Disorder)
01/2017 - 01/2011
2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
02/2012 - 01/2011
2Mental Disorders (Mental Disorder)
01/2010 - 01/2007
2Heart Failure
01/2009 - 01/2009
2Cocaine-Related Disorders (Cocaine Addiction)
08/2008 - 01/2004
2Pain (Aches)
07/2008 - 08/2007
1Colonic Neoplasms (Colon Cancer)
01/2023
1Carcinoma (Carcinomatosis)
01/2023
1COVID-19
01/2022
1Hypoxia (Hypoxemia)
01/2022
1Post-Acute COVID-19 Syndrome
01/2022
1Fibromyalgia (Fibrositis)
01/2022
1Major Depressive Disorder (Major Depressive Disorders)
02/2020

Drug/Important Bio-Agent (IBA)

19Antidepressive Agents (Antidepressants)IBA
01/2023 - 02/2004
8Fluoxetine (Prozac)FDA LinkGeneric
01/2023 - 02/2004
8CytokinesIBA
01/2023 - 11/2009
7Desipramine (Pertofrane)FDA LinkGeneric
01/2023 - 11/2009
7Immunoglobulin M (IgM)IBA
02/2020 - 02/2008
5Tryptophan (L-Tryptophan)FDA Link
02/2020 - 12/2007
5Interleukin-10 (Interleukin 10)IBA
02/2020 - 12/2011
5Immunoglobulin A (IgA)IBA
02/2020 - 02/2008
5GlucocorticoidsIBA
03/2018 - 01/2007
5AntibodiesIBA
09/2013 - 01/2010
5AntioxidantsIBA
04/2011 - 06/2008
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 04/2011
4CorticosteroneIBA
03/2014 - 07/2008
4NeopterinIBA
02/2012 - 01/2012
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2015
3EpitopesIBA
02/2020 - 02/2012
3Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
03/2018 - 12/2004
3Sucrose (Saccharose)IBA
07/2017 - 07/2013
3Interleukin-6 (Interleukin 6)IBA
01/2016 - 01/2013
3HaptensIBA
10/2015 - 01/2013
3AntigensIBA
10/2015 - 01/2013
3InterferonsIBA
03/2014 - 01/2011
3LipopolysaccharidesIBA
02/2012 - 02/2004
3Antipsychotic Agents (Antipsychotics)IBA
01/2011 - 11/2002
3EnzymesIBA
12/2010 - 12/2007
3StaurosporineIBA
11/2009 - 07/2007
3Cocaine (Cocaine HCl)IBA
08/2008 - 11/2003
2Mirtazapine (Rexer)FDA LinkGeneric
01/2023 - 01/2013
2InterleukinsIBA
01/2022 - 04/2011
2ChemokinesIBA
02/2020 - 01/2017
2Acute-Phase Proteins (Acute-Phase Protein)IBA
02/2020 - 01/2016
2KynurenineIBA
08/2019 - 12/2007
2Kynurenic Acid (Kynurenate)IBA
01/2018 - 12/2007
2Serotonin (5 Hydroxytryptamine)IBA
09/2013 - 02/2012
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2013 - 11/2009
2MitogensIBA
01/2013 - 06/2004
2Interleukin-1 (Interleukin 1)IBA
02/2012 - 02/2012
2Muramidase (Lysozyme)IBA
02/2012 - 02/2012
2Phosphotransferases (Kinase)IBA
04/2011 - 11/2003
2Brain-Derived Neurotrophic Factor (BDNF)IBA
04/2011 - 03/2005
2PeroxidesIBA
04/2011 - 09/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2010 - 11/2009
2Amantadine (Aman)FDA LinkGeneric
11/2009 - 11/2009
2coenzyme Q10 (CoQ10)IBA
01/2009 - 01/2009
2NeurosteroidsIBA
09/2008 - 11/2003
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
09/2008 - 11/2006
2Dehydroepiandrosterone SulfateIBA
09/2008 - 11/2003
21 alpha,24-dihydroxyvitamin D3 (Tacalcitol)IBA
07/2007 - 11/2006
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022
1CateninsIBA
01/2022
1CalciumIBA
01/2022
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2022
1N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA
01/2022
1Caspase 1 (ICE Protease)IBA
01/2022
1Peroxidase (Myeloperoxidase)IBA
01/2022
1Advanced Oxidation Protein Products (AOPP)IBA
01/2022
1Polytetrafluoroethylene (Teflon)FDA Link
02/2020
1Complement System Proteins (Complement)IBA
02/2020
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
02/2020
1Interleukin-4 (Interleukin 4)IBA
02/2020
1Immunoglobulins (Immunoglobulin)IBA
02/2020
1HaptoglobinsIBA
02/2020
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2020

Therapy/Procedure

2Injections
01/2023 - 07/2013
2Therapeutics
01/2018 - 01/2004